Journal: Science Advances
Article Title: LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
doi: 10.1126/sciadv.adi3821
Figure Lengend Snippet: ( A ) Luciferase reporter assays showing the transcriptional activity in MCF7-palR cells transfected with truncated fragments of the EILA promoter region. ( B ) Predicted transcriptional factors of EILA in the JASPAR online software based on the −500- to 0-bp sequence. ( C ) qRT-PCR analysis of CTCF and EILA expression in MCF7-palR cells after CTCF knockdown. ( D ) Luciferase reporter assays showing the EILA transcriptional activity in MCF7-palR cells after CTCF knockdown. ( E ) Luciferase reporter assays performed in MCF7-palR cells transfected with mutated fragments of the EILA promoter region (−500 to 0 bp). ( F ) Predicted CTCF-binding site in the EILA promoter region. ( G ) ChIP-qPCR analysis revealing the localization of CTCF at EILA promoter in MCF7-palR cells. ( H ) Analysis of ChIP-seq binding peaks in the Cistrome Database and UCSC Genome Browser. ( I ) ChIP-qPCR analysis showing the localization of CDK8 at EILA promoter in MCF7-palR cells. ( J ) Co-IP assays and Western blot analysis showing the interaction between CTCF and CDK8/TFII-I in MCF7-palR cells. In ( K to M ), CDK8 was silenced in MCF7-palR cells. (K) qRT-PCR detection of CTCF and EILA in MCF7-palR cells after CTCF knockdown. (L and M) Cell proliferation assays (L) and EdU incorporation (M) assays showing the growth of transfected cells under palbociclib treatment. For (A), (C) to (E), (G), (I), and (K) to (M), data from three independent experiments were expressed as means ± SD and the P values were calculated by Student’s t test for two-group comparison and one-way ANOVAs for multiple-group comparison. **** P < 0.0001, *** P < 0.001, ** P < 0.01, and N.S. for P > 0.05.
Article Snippet: Antibodies against CTCF (3418, CST, 1:50), CDK8 (sc-1521, Santa Cruz Biotechnology, 1:50), and rabbit/mouse IgG were used for immunoprecipitation, and the precipitated DNA fragments were subjected to qPCR amplification.
Techniques: Luciferase, Activity Assay, Transfection, Software, Sequencing, Quantitative RT-PCR, Expressing, Knockdown, Binding Assay, ChIP-qPCR, ChIP-sequencing, Co-Immunoprecipitation Assay, Western Blot, Comparison